Last update 08 May 2025

URAT1 x GLUT9

Basic Info

Related Targets
URAT1GLUT9

Related

1
Drugs associated with URAT1 x GLUT9
Isobavachin
Target
GLUT9 x URAT1 x Xanthine oxidase
Mechanism
GLUT9 inhibitors [+2]
Active Org.
Korea Institute of Oriental Medicine [+1]
Originator Org.
Southern Medical UniversitySouthern Medical University
Active Indication
Inflammation [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with URAT1 x GLUT9
Login to view more data
100 Translational Medicine associated with URAT1 x GLUT9
Login to view more data
0 Patents (Medical) associated with URAT1 x GLUT9
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free